How pharma is teaming up to improve patient adherence and cut costs

Medication non-adherence costs are skyrocketing. Approximately 50 percent of patients do not take their medication as prescribed, costing pharmaceutical companies an estimated $637 billion in revenue each year. At the same time, pharmaceutical companies are feeling pressure to differentiate themselves from the competition in the eyes of providers by offering value-based, “beyond-the-pill” services. In light of these trends, pharma companies are partnering with vendors and payers to deliver value and improve adherence.

Most of the large pharmaceutical companies are working with vendors to power their patient support programs. The programs aim to improve patient adherence and engagement for chronic conditions through education and support. While the various patient programs have similar goals, they seek to differentiate themselves with unique offerings. For example, for basic diabetes education, most pharma companies offer web and print content with topics ranging from blood glucose to nutrition and activity.